Cargando…
Ozanimod-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis
Ozanimod is an oral sphingosine-1-phosphate receptor modulator. Although it can be an effective drug for the induction and maintenance of remission in patients with moderately to severely active ulcerative colitis, there have been a few reported cases of various malignancies after exposure to this s...
Autores principales: | Sandlow, Sarah, Rai, Puja, Shum, Ann, Chen, Hannah, Arnold, Jeffrey, Jangi, Sushrut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915949/ https://www.ncbi.nlm.nih.gov/pubmed/36788790 http://dx.doi.org/10.14309/crj.0000000000000929 |
Ejemplares similares
-
Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis
por: Wetwittayakhlang, Panu, et al.
Publicado: (2021) -
Human herpesvirus-8 positive iatrogenic Kaposi's sarcoma in the setting of refractory ulcerative colitis
por: Duh, Erica, et al.
Publicado: (2017) -
Ozanimod: A Review in Ulcerative Colitis
por: Paik, Julia
Publicado: (2022) -
Correction to: Ozanimod: A Review in Ulcerative Colitis
por: Paik, Julia
Publicado: (2022) -
Kaposi Sarcoma Mimicking Acute Flare of Ulcerative Colitis
por: Kumar, Vivek, et al.
Publicado: (2017)